Acetylcholinesterase: A multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer’s disease

Author： Greenblatt Harry Dvir Hay Silman Israel Sussman Joel

Publisher： Humana Press, Inc

ISSN： 0895-8696

Source： Journal of Molecular Neuroscience, Vol.20, Iss.3, 2003-08, pp. : 369-383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cdk5 as a Drug Target for the Treatment of Alzheimer’s Disease

By Lau Lit-Fui Seymour Patricia A. Sanner Mark A. Schachter Joel B.

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 267-274

Humana Press, Inc

Access to resources Recommend Favorite

Tau as a Drug Target in Alzheimer’s Disease

By Gozes Illana

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 337-338

Humana Press, Inc

Access to resources Recommend Favorite

The BRAINz trial: a novel approach to acetylcholinesterase-inhibitor treatment for Alzheimer’s disease

By Wilkinson David Roughan Laura

Future Neurology, Vol. 2, Iss. 4, 2007-07 ,pp. : 379-382

Future Medicine

Access to resources Recommend Favorite

The β-secretase, BACE: A prime drug target for Alzheimer’s disease

By Vassar Robert

Journal of Molecular Neuroscience, Vol. 17, Iss. 2, 2001-10 ,pp. : 157-170

Humana Press, Inc

Access to resources Recommend Favorite

Tuberin – A New Molecular Target in Alzheimer’s Disease?

By Ferrando-Miguel Rosa Rosner Margit Freilinger Angelika Lubec Gert Hengstschläger Markus

Neurochemical Research, Vol. 30, Iss. 11, 2005-11 ,pp. : 1413-1419

Springer Publishing Company

Access to resources Recommend Favorite